Objective. Misclassification of smokers as non-smokers may bias estimates of the excess morbidity and mortality associated with smoking. The issue has been given little, if any, attention in prospective epidemiological studies. This study examined characteristics of potentially misclassified smokers with respect to mortality, morbidity, and risk factors. Method. A prospective study (within The Copenhagen Male Study, Denmark) used serum cotinine as an objective marker of use of tobacco. A serum concentration of 100 ng/ml was regarded as a relevant threshold for active smoking. In all, 3270 males aged 53-74 years who reported their previous and current tobacco habits, including the use of chew tobacco and snuff, were included. Incidence of all causes of mortality (ACM) during 9 years and death due to ischaemic heart disease (IHD) during 8 years of follow-up were the main outcome measures. Results. Overall cumulative incidence rates of ACM and IHD were 19.1% and 4.3%, respectively. Of 1405 men who reported being non-tobacco users, i.e no current smoking and no use of chewing tobacco or snuff, 1377 had levels Ͻ100 ng/ml, 28 men (2%) had levels equal to or above this threshold value and were considered potentially misclassified smokers. They had significantly higher mortality rates, 35.7% versus 14.7%, P Ͻ 0.001, than other self-reported nontobacco users, and a slightly higher prevalence of tobacco-related cancer, and a highly significant higher prevalence of myocardial infarction, P Ͻ 0.001. Compared to non-tobacco users with low cotinine, age-adjusted relative risks (95% CI) were 2.4 (1.3-4.5), P Ͻ 0.01, for ACM, and 5.3 (95% CI : 2.1-13.4), P Ͻ 0.001, for IHD. Conclusions. Potentially misclassified smokers deviated strongly from other non-smokers with respect to mortality and morbidity. The importance of this reporting bias when estimating the risk associated with active or passive smoking is discussed.
Tobacco smoking is an established risk factor for a large number of diseases increasing the risk of premature mortality, and also exposure to environmental tobacco smoke, 'passive smoking', has been associated with increased risk of lung cancer and other diseases. [1] [2] [3] Misclassification of smokers as non-smokers is a source of bias in epidemiological studies estimating the risk associated with tobacco smoking. With respect to active smoking and risk, misclassification will dilute an observed association. Accordingly, an excess risk associated with active smoking may be underestimated or, if active smoking is associated with an only modest increase in risk, perhaps overlooked. In more complex situations, a passive smoking bias may arise, i.e. disease occurrence may incorrectly be ascribed to the exposure to passive smoking. It has been shown that smokers tend to marry smokers. 4 Misclassified smokers might therefore report that they themselves do not smoke but that their spouse does, and misclassification of smokers as non-smokers might cause an apparent relationship of spousal smoking to premature mortality. As discussed by Lee, 5 factors critically determining the size of this bias are, the assumed relative risk of active smoking, the degree of concordance of tobacco use among spouses, and the level of misclassification of smokers and non-smokers.
If misclassification of smokers as non-smokers should be regarded as a relevant source of bias in mortality studies, misclassified smokers must also deviate from other self-reported non-smokers with respect to mortality. This relevant methodological consideration has been given very little, if any, attention in prospective studies. To further elucidate the issue this study examined characteristics of potentially misclassified smokers with respect to mortality, baseline morbidity, and a number of risk factors for premature death.
SUBJECTS AND METHODS
The Copenhagen Male Study was set up in 1970 as a prospective cardiovascular study. 6, 7 The men came from 14 large work places in Copenhagen, the air force, the army, the navy, the emergency management agency, the post service, the customs service, a railroad company, the national bank, a telephone company, three municipal service centres for electricity, engineering and a fire brigade, the pharmaceutical industry, and a building contractor company. All employed men (6125 aged 40-59 years [mean 48]) were invited, from the managing director to the porter. In total, 5249 men participated (87%).
In 1985-1986, a new baseline which was used for this study was established. All survivors from the 1970 study were traced by means of the Danish Central Population Register. Between June 1985 and June 1986, all 4505 survivors (except 34 emigrants) from the original cohort were invited to take part in this study. In all 3387 (75%) men participated, and gave informed consent; their mean age was 63 years (range 53-74).
Each subject was interviewed by a physician about a previously completed questionnaire and examined, with measurements of height, weight, and blood pressure; a venous blood sample was taken after the subject had fasted for at least 12 h for measurements of serum cotinine, serum lipids, Lewis blood types, and serum selenium.
The men classified themselves as never smokers, previous smokers, or current smokers. Current tobacco smoking was calculated from information about the number of cigarettes, cheroots, cigars, or the weight of pipe tobacco smoked daily. One cigarette was taken as equivalent to 1 g tobacco, one cheroot as 3 g, and one cigar as 4 g tobacco. As regards leisure time physical activity, the men classified themselves as either physically active Ͻ4 h/week, or physically more active.
Total weekly alcohol consumption was calculated from questionnaire items about average alcohol consumption on weekdays and at weekends. Intakes of beer, wine and spirits were reported separately. One drink corresponded to 10-12 g ethanol.
According to a system by Svalastoga, 8 later adjusted, the men were classified into five social classes, based on level of education and job profile. Strata were defined as follows; class I: Self-employed subjects with at least 21 employees and white collar workers with at least 51 subordinates or subjects with an academic degree; typical jobs in the study cohort were: officer, civil engineer, office executive, head of department. Social class II: Self-employed administrators with 6-20 white collar workers with 11-50 subordinates or with an intermediate education; typical jobs: head clerk, engineer, non-academic architect. Social class III: Selfemployed subjects with 1-5 employees and white collar workers with 1-10 subordinates; typical jobs: engine driver, train guard. Social class IV: Self-employed subjects without employees, white collar workers without subordinates or without qualified work, and skilled blue collar workers; typical jobs: machine fitter in a telephone company, station foreman. Social class V: Unskilled blue collar workers; typical jobs: unskilled labourer, mechanic, driver. For presentation purposes in Tables classes I, II and III were pooled (high), and classes IV and V were pooled (low).
Serum measurements of the primary nicotine metabolite, cotinine, were used to validate the information given by study participants. To determine serum concentrations of cotinine radio-immuno assay (RIA) was performed at Medi-Lab, Copenhagen, using the method developed by Knight et al., 9 albeit with a different batch of rabbit-anti-cotinine antibody. The method has an estimated lower limit of sensitivity of 5 ng/ml. A study by Anderson et al. 10 compared the measurement of serum cotinine levels by gas chromatography and RIA. The authors demonstrated a high correlation between the two with cotinine levels Ͼ50 ng/ml. However, RIA gave 60% higher values than gas chromatography. With cotinine levels Ͻ50 ng/ml the correlation between RIA and gas chromatography was small and not significant. All men who reported their current smoking habits, i.e. whether they smoked daily, occasionally or not, who reported the daily amount of tobacco used in grams, who reported if they used chewing tobacco or snuff, or, if they had done so in the past, the year of cessation, and who had successful determinations of cotinine, were considered eligible for study; n = 3270 men (96.6%). Among men who reported current smoking and reported the amount smoked, 95% had serum cotinine levels Ͼ100 ng/ml. Of those who reported never having smoked, none had serum cotinine levels Ͼ100 ng/ml. As previously shown 11 100 ng/ml seemed a relevant threshold for the potentially misclassified smoker.
Serum lipids, high density lipoprotein cholesterol (HDL-C) and triglycerides (TG), were determined using standardized methods. [12] [13] [14] [15] Low density lipoprotein cholesterol (LDL-C) was calculated from the above. 16 Lewis typing was carried out on erythrocytes using a saline haemagglutination technique in test tubes with monoclonal a and b antibodies (Seraclone, Biotest, Dreieich, Germany). 6 One drop of antibody was mixed with one drop of 5% erythrocyte suspension, and read macroscopically. Serum selenium level was determined by a graphite furnace atomic absorption spectrophotometric method, after a simple dilution with a solution containing nickel and nitric acid.
Blood pressure was measured on the right arm with the subject seated using a manometer developed by London School of Hygiene. 18 Hypertension was defined as receiving antihypertensive treatment or having a systolic blood pressure у150 mmHg and a diastolic blood pressure у100 mmHg. Body mass index (BMI) was calculated as weight in kg/height in m 2 . Chronic bronchitis was defined from a slightly modified version of the British Medical Research Council questionnaire on respiratory symptoms as cough and phlegm lasting у3 months within the preceding 2 years. 19 Self-reported cancer history was accepted, if verified by the Danish Cancer Registry. The men reported whether they took medicine on a regular basis, their self-assessed state of health, and whether they had non-insulin dependent diabetes mellitus (NIDDM).
For all who reported admission to hospital because of acute myocardial infarction before the start of the study, we checked hospital records, n = 151 (4.6%). The diagnosis was accepted if at least two of the following symptoms/signs were recorded: retrosternal pain lasting Ͼ20 min., typical, serial electrocardiographic changes in more than two electrocardiograms, acute increase of relevant serum enzymes (alanine aminotransferase, lactate dehydrogenase or creatinine phosphokinase MB). It had no influence on the results whether we used hospital confirmed or self-reported history of infarction. Accordingly, in the Tables we present all who reported that they had previously had a myocardial infarction event, n = 172 (5.3%). Information on angina pectoris was according to questionnaire 20 and confirmed by a physician; intermittent claudication was established from the questionnaire 20 or stroke (verified by a doctor). In 1995 a register follow-up was carried out on mortality between 1985-1986 and 31 December 1994. Death certificate diagnoses were available for the period 1985-1986 to 31 December 1993. Ischaemic heart disease (IHD) diagnoses accepted were codes 410-414, International Classification of Diseases, 8th Revision.
Chi-squared or non-parametric Mann-Whitney tests have been used for testing possible differences in the distribution of characteristics of men with serum cotinine levels above and below 100 ng/ml. To estimate which characteristics separated high and low cotinine groups, and those who died from all causes or IHD from others, logistic and Cox proportional hazards regression analyses were applied using the maximum likelihood ratio method. All basic analyses and the regression analyses were performed using the SPSS statistical software for Windows. 21, 22 A P-value of р0.05 was taken as significant.
The study was approved by The Ethics Committee for Medical Research, in the County of Copenhagen. Table 1 presents lipid, lifestyle, and clinical characteristics of self-reported non-tobacco users with serum cotinine levels above and below the cutoff point used as a threshold value for potentially misclassified smokers, i.e. 100 ng/ml. Some 28 men in this group had serum cotinine above this level and 1377 men had cotinine below it. Among the 28 potentially misclassified smokers two characteristics significantly separated them from others: Their diastolic blood pressure was 6 mmHg lower, and they had a much higher prevalence of men with the Lewis blood group phenotype Le(a-b-). Table 2 shows health and sociodemographic characteristics of self-reported non-tobacco users with serum cotinine levels Ͻ100 ng/ml and with serum cotinine levels у100 ng/ml. History of myocardial infarction was highly significantly more common among those potentially misclassified, and also use of medicine, cancer history, angina pectoris, claudication and bronchitis were more prevalent among those potentially misclassified. Table 3 presents lipid, lifestyle, and clinical characteristics of self-reported tobacco users with serum cotinine levels above and below the cutoff point used as a threshold value for potentially misclassified smokers, i.e. 100 ng/ml. Some 1656 men in this group had serum cotinine above this level and 209 men had cotinine below it. A number of characteristics significantly separated the low cotinine group from others: They had a slightly higher serum HDL-C. Almost all occasional smokers belonged to this group, their average tobacco use was lower, the systolic and diastolic blood pressure were both lower, and only about 25% had a low serum selenium concentration as compared with almost 35% among those with high cotinine. Table 4 shows health and sociodemographic characteristics of self-reported tobacco users with serum cotinine levels Ͻ100 ng/ml and with serum cotinine levels у100 ng/ml. Intermittent claudication and bronchitis were significantly more common among tobacco users with high cotinine, and those with low cotinine also comprised a smaller proportion of men from low social classes. Table 5 shows crude incidence rates of ACM, and of death from IHD according to self-reported tobacco use habits and serum level of cotinine. The highest incidence rates with respect to ACM as well as IHD were found for self-reported non-tobacco users with cotinine levels Ͼ100 ng/ml, the lowest incidence rates were found for self-reported non-tobacco users with low cotinine levels. Relevant P-values are presented in the relative risk analyses in Table 6 . Table 6 shows the results of Cox proportional hazards regression analyses estimating the relative risk (RR) of ACM and IHD, comparing the risk of the high cotinine concentration group with that of the low cotinine group in the self-reported non-tobacco user group, and comparing the risk of the low cotinine concentration group with that of the high cotinine group in the self-reported tobacco user group. Among selfreported tobacco users there were no significant differences between the high and low cotinine group with respect to ACM and IHD, but with both outcomes after the inclusion of potential confounders in the analyses, the risk was slightly smaller among those with low cotinine. Among self-reported non-tobacco users, men with high serum cotinine values had an almost tripled risk of premature death. Adjustment for potentially confounding factors, or potentially explanatory mediating covariates, reduced the RR to a not significant 1.5. With respect to risk of IHD there was a more than sixfold increased risk among the potentially misclassified men. Multivariable adjustment reduced this to a not significant RR of 2.6. Finally, we analysed the level of cotinine among the 28 potentially misclassified men. The median value with 5 and 95 percentile values was 196 ng/ml (106 and 1420) ng/ml. Among 1675 self-reported active smokers it was 350 ng/ml (70 and 700) ng/ml, and among never smokers, 11.5 (0 and 87) ng/ml after the exclusion of users of chewing tobacco and snuff (not shown in Table) . a Cancer of lip, tongue, pharynx, larynx, trachea, lung and bladder. * P р 0.05; ** P р 0.01; *** P р 0.001.
RESULTS

TABLE 5 Cumulative incidence of all causes of mortality (ACM) during the 9-year follow-up and ischaemic heart disease (IHD) (8 years of follow-up) according to self-reported use of tobacco and level of serum cotinine
Self-reported tobacco use category
No tobacco use Use tobacco у100 ng/ml Ͻ100 ng/ml у100 ng/ml Ͻ100 ng/ml (n = 28) (n = 1377) (n = 1656) (n = 209)
End point ACM, % (n) 35. No tobacco use Use tobacco у100 ng/ml Ͻ100 ng/ml у100 ng/ml Ͻ100 ng/ml 
DISCUSSION
This study of middle-aged and elderly men showed that potentially misclassified smokers deviated strongly from other self-reported non-smokers with respect to mortality, baseline morbidity, and a number of risk factors for premature death. Compared with apparently correctly classified nonsmokers, potentially misclassified smokers had a more than twofold increased risk of premature death, and a more than fivefold excess risk of death from IHD. The excess risk was in part accounted for when adjustments were made in the regression analyses. Only 28 men were identified as misclassified, corresponding to 2% of selfreported non-tobacco users, so occasional type II errors cannot be excluded when comparing characteristics of this group with other self-reported non-smokers.
A number of significant differences were found. Potentially misclassified smokers had lower blood pressure than other self-reported non-smokers. It is well known that smokers have a lower blood pressure than non-smokers. In this study blood pressure levels were the same in those potentially misclassified, and in men who reported that they were active smokers and had cotinine levels у100 ng/ml, further supporting the circumstantial evidence that the group actually comprised active smokers. Misclassified smokers had a higher proportion of men with the Lewis blood group phenotype Le(a-b-) and a higher proportion of men with a history of myocardial infarction. In the Copenhagen Male Study we have previously shown that men with this Lewis phenotype had a higher prevalence of myocardial infarction in the entire cohort, and in a prospective study, excluding those with cardiovascular disease at baseline, that they had a significantly higher risk of death from IHD. Men with tobacco-related diseases have no doubt been advised to give up smoking, and they might be embarrassed to report continued smoking despite their disease. Accordingly, it is likely that the high prevalence of Le(a-b-) among potentially misclassified smokers does not reflect a genetic inclination to lie but a higher risk of cardiovascular disease among Le(a-b-). Some of the highest misclassification rates have been found in tobacco cessation studies, 23 suggesting also that in intervention studies estimation of the risk associated with smoking, active or passive, should be done with care.
An important potential bias in this study should be addressed. Was classification of men into high and low cotinine groups exclusively determined by the use of tobacco?
High cotinine in non-smokers not using chewing tobacco or snuff cannot be explained by a high exposure to passive smoking-20 or 30 ng/ml is normally used as the cutoff to distinguish misclassified smokers. As mentioned in the Methods section of this paper the method used for determination of cotinine gave 60% higher values than gas chromatography, and even when taking this into account, passive smoking exposure would not be able to reach the 100 ng/ml cutoff point for active smoking used in this study. Other sources of nicotine such as tomatoes, egg plants and tea might increase the level of serum cotinine but not nearly enough to be relevant. 5 Neither nicotine chewing gum nor nicotine patches were on sale in 1985/86, and there seems to be no reason for our study participants not to have reported correctly their use of chewing tobacco and snuff. It can be argued that the category of nonsmokers with high cotinine levels may in fact be former smokers that have recently stopped smoking, for instance due to health problems. That would explain their increased risk. However, in smokers the half life of serum cotinine is only 18 h. 24 The self-reported nonsmoker with high cotinine should thus regard himself as a former smoker based on maximum 2 to 3 days of smoking cessation. This is not a likely explanation. High cotinine in non-smokers not using chewing tobacco or snuff must predominantly be due to undisclosed smoking.
Low cotinine in smokers may arise for a number of reasons, e.g. if they only smoke little, and if they do not inhale. Our study showed that smokers with low cotinine smoked much less than smokers with higher levels of cotinine. We did not include the issue of inhalation in this study. In our previous study using cotinine as a marker, 11 it was shown that, with the same amount smoked, inhalers had a serum cotinine level approximately 100 ng/ml higher as compared with smokers who did not inhale. Another reason why smokers may have low cotinine despite their smoking habit is that they differ metabolically from other smokers. The major pathway of metabolism of nicotine is C-oxidation of cotinine. 25 Cotinine has a much longer half life than nicotine, and with a deficiency in this metabolic pathway, the result is little generation of cotinine, and usually a slow metabolism of nicotine. Finally, there is the possibility that some men falsely claim that they smoke, which seems unlikely.
Our results support previous suggestions that misclassification of smokers as non-smokers may be a problem, in particular with respect to estimating possible adverse health effects of passive smoking. To which extent and in which direction a deceiver bias may influence results, has been discussed previously by Lee 5 , and Tweedie et al. 26 have given a guide on how to adjust for the effects of poor data. One basic assumption when attempting to 'reclassify' smokers is that the RR of misclassified smokers is equal to that of the selfreported correctly classified smoker. Our results suggest that health and mortality characteristics of misclassified are even worse than those of self-reported active smokers, supporting the relevance of attempting to reclassify misclassified smokers.
